CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Flagship's Abiologics uses AI to build mirror-image proteins for new drugs

Positive
AI Analysis

Summary

Abiologics, a Flagship Pioneering-founded startup, has developed an AI approach to create mirror-image proteins that could potentially lead to more durable drug candidates.

Importance:3/10
Sentiment:
0.60
artificial intelligenceprotein engineeringmirror-image proteinsdrug developmentstartup
Related Companies

Read the original article

Published by Endpoints News on June 23, 2026 10:00 AM

Read Original